These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Effects of riluzole on symptom progression in amyotrophic lateral sclerosis. Sojka P; Andersen PM; Forsgren L Lancet; 1997 Jan; 349(9046):176-7. PubMed ID: 9111546 [No Abstract] [Full Text] [Related]
84. Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics. Dash RP; Babu RJ; Srinivas NR Clin Pharmacokinet; 2018 Nov; 57(11):1385-1398. PubMed ID: 29682695 [TBL] [Abstract][Full Text] [Related]
85. An acute, life-threatening, hypersensitivity reaction to riluzole. Sorenson EJ Neurology; 2006 Dec; 67(12):2260-1. PubMed ID: 17190960 [No Abstract] [Full Text] [Related]
86. Associations between co-medications and survival in ALS-a cohort study from Austria. Cetin H; Klickovic U; Rath J; Zulehner G; Füzi J; Reichardt B; Hagmann M; Wanschitz J; Löscher WN; Auff E; Zimprich F J Neurol; 2015 Jul; 262(7):1698-705. PubMed ID: 25957641 [TBL] [Abstract][Full Text] [Related]
87. [What are the etiological medical therapies in amyotrophic lateral sclerosis?]. Dib M Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114 [TBL] [Abstract][Full Text] [Related]
88. Controversies about databases. Swash M Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):107. PubMed ID: 12495569 [No Abstract] [Full Text] [Related]
89. Reversible granulocytopenia in association with riluzole therapy. North WA; Khan AM; Yamase HT; Sporn JR Ann Pharmacother; 2000 Mar; 34(3):322-4. PubMed ID: 10917377 [TBL] [Abstract][Full Text] [Related]
91. Clinical features of amyotrophic lateral sclerosis in south-west China. Wei Q; Chen X; Zheng Z; Huang R; Guo X; Cao B; Zhao B; Shang H Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):512-9. PubMed ID: 26203659 [TBL] [Abstract][Full Text] [Related]
92. Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. Limousin N; Blasco H; Corcia P; Gordon PH; De Toffol B; Andres C; Praline J J Neurol Sci; 2010 Oct; 297(1-2):36-9. PubMed ID: 20673675 [TBL] [Abstract][Full Text] [Related]
93. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis. Sommer M; Tergau F; Wischer S; Reimers CD; Beuche W; Paulus W J Neurol; 1999 Nov; 246 Suppl 3():III22-6. PubMed ID: 10631657 [TBL] [Abstract][Full Text] [Related]
95. Trends of quality of life changes in amyotrophic lateral sclerosis patients. Shamshiri H; Fatehi F; Abolfazli R; Harirchian MH; Sedighi B; Zamani B; Roudbari A; Razazian N; Khamseh F; Nafissi S J Neurol Sci; 2016 Sep; 368():35-40. PubMed ID: 27538598 [TBL] [Abstract][Full Text] [Related]
96. Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study. Luna J; Diagana M; Ait Aissa L; Tazir M; Ali Pacha L; Kacem I; Gouider R; Henning F; Basse A; Cisse O; Balogou AAK; Kombate D; Agbetou M; Houinato D; Millogo A; Agba T; Belo M; Penoty M; Raymondeau-Moustafa M; Hamidou B; Couratier P; Preux PM; Marin B; J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):20-29. PubMed ID: 30242088 [TBL] [Abstract][Full Text] [Related]